NEW YORK (Reuters Health) – Compared with a strategy of optimal medical therapy alone for treatment of stable coronary artery disease (CAD), the addition of percutaneous coronary intervention…
NEW YORK (Reuters Health) – Adherence to a healthy diet and lifestyle can reduce the lifetime risk of heart failure and the risk of incident hypertension, according to…
NEW YORK (Reuters Health) – Although the rate of hysterectomy after cesarean delivery has declined over the past decade, the procedure remains an “uncommon, but not rare” complication…
NEW YORK (Reuters Health) – Pitavastatin is equivalent to atorvastatin in its ability to reduce coronary plaque volume in patients with acute coronary syndrome (ACS), Japanese researchers have…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik or laser vision correction, which is a great option for those who…
Hylton Mayer, MD, Assistant Clinical Professor Yale University Department of Opthalmology, discusses capsular tension rings, plastic like device used at the time of cataract surgery to assist in…
Jonathan Sears, MD, Associate Professor of Ophthalmology, Cole Eye Institute, Cleveland Clinic, discusses retinopathy of prematurity, which affects 10-15% of the 500,000 premature infants born annually in the…
NEW YORK (Reuters Health) – The outcome of treatment for early prostate cancer depends on the patient’s sexual, bowel and urinary function at baseline. These factors also influence…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
